Chartwell Investment Partners, LLC, released the Q2 2024 investor letter for the Carillon Chartwell Small Cap Value Fund, discussing interest rate volatility, AI boom, and market performance. Enovis Corporation was highlighted as a medical tech stock in the fund's top picks.